To explore whether the relationship between ACOT12 and EMT is also involved in the progression of glioma, we validated the effect of modulating ACOT12 expression on the expression levels of TWIST2 and other EMT markers, including vimentin and N-cadherin, by RT-qPCR and western blotting. This evidence concerns the gene VIM and central nervous system cancer.